Mesenchymal Cell News Volume 12.48 | Dec 8 2020

    0
    36







    2020-1-12 | MESCN 12.47


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 12.47 – 8 December, 2020
    TOP STORY

    Transcriptome
    and Regulatory Maps of Decidua-Derived Stromal Cells Inform Gene Discovery in Preterm Birth

    Researchers generated transcriptome (RNA-seq), epigenome (ChIP-seq of H3K27ac, H3K4me1, and H3K4me3 histone modifications), open chromatin (ATAC-seq), and chromatin interaction (promoter capture Hi-C) annotations of cultured primary decidua-derived MSCs and in vitro differentiated decidual stromal cells and developed a computational framework to integrate these functional annotations with results from a GWAS of gestational duration in 56,384 women.
    [Science Advances]

    Full ArticlePress Release


    Webinar: Bone Marrow Skeletal Progenitors and Bone Diseases
    PUBLICATIONSRanked by the impact factor of the journal
    IN VITRO

    Epigenomic
    Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis

    The authors show that, in addition to cancer cell epithelial-to-mesenchymal transition, ovarian cancer cell metastasis relies on an epigenomic mesenchymal-to-epithelial transition in host MSCs. These reprogrammed MSCs, termed carcinoma-associated MSCs, acquired pro-tumorigenic functions and directly bind cancer cells to serve as a metastatic driver/chaperone.
    [Cell Reports]

    Full ArticleGraphical Abstract

    The
    Chemokine Receptors Ccr5 and Cxcr6 Enhance Migration of Mesenchymal Stem Cells into the Degenerating Retina

    Scientists identified the chemokines that were most upregulated during retinal degeneration and that could chemoattract MSCs.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Human
    Mesenchymal Stem Cell-Engineered Length Scale Dependent Rheology of the Pericellular Region Measured with Bi-Disperse Multiple Particle Tracking Microrheology

    Researchers characterized length scale dependent rheology in a well-established 3D cell culture platform for human (h)MSCs. hMSCs re-engineered their microenvironment through matrix metalloproteinase secretions and cytoskeletal tension.
    [Acta Biomaterialia]

    AbstractGraphical Abstract

    Impact
    of Tranexamic Acid on Chondrocytes and Osteogenically Differentiated Human Mesenchymal Stromal Cells (hMSCs) In Vitro

    Investigators examined the effects of varying exposure times and concentrations of tranexamic acid on proliferation rates, gene expression and differentiation capacity of chondrocytes and hMSCs, which underwent osteogenic differentiation.
    [Journal of Clinical Medicine]

    Full Article

    Synthesis
    of Aligned Porous Polyethylene Glycol/Silk Fibroin/Hydroxyapatite Scaffolds for Osteoinduction in Bone Tissue Engineering

    The effect of the biophysical microenvironment on rat bone marrow MSC osteogenesis was studied both in vitro and in vivo.
    [Stem Cell Research & Therapy]

    Full Article

    MSCs-Extracellular
    Vesicles Attenuated Neuroinflammation, Synapse Damage and Microglial Phagocytosis After Hypoxia-Ischemic Injury by Preventing Osteopontin Expression

    MSCs-extracellular vesicles treatment remarkably restored synaptic reorganization and up-regulated synaptic protein expression post-hypoxia-ischemic, concomitant with reducing osteopontin levels.
    [Pharmacological Research]

    AbstractGraphical Abstract

    Menstrual
    Blood-Derived Stromal Cells Modulate Functional Properties of Mouse and Human Macrophages

    Scientists assessed the effects that menstrual blood-derived stromal cells had on the recruitment of macrophages and other innate immune cells in two mouse models of acute inflammation, a thioglycollate-elicited peritonitis model and a monobacterial sepsis model.
    [Scientific Reports]

    Full Article

    Deficit
    in Adipose Differentiation in Mesenchymal Stem Cells Derived from Chronic Rhinosinusitis Nasal Polyps Compared to Nasal Mucosal Tissue

    MSC cultures were induced to differentiate toward adipocytes, where lipid droplets and adipocyte genes PPARγ2, ADIPO-Q, and FABP4 were observed in control non-polyp nasal mucosa-derived mesenchymal cells but were scarcely present in the cultures derived from the nasal polyps, where apoptosis was evident.
    [International Journal of Molecular Sciences]

    Full Article

    IN VIVO

    Mesenchymal Stem Cell-Derived Neural Progenitors in Progressive MS

    Investigators determined the long-term safety and efficacy of repeated intrathecal administration of autologous MSC-derived neural progenitors in patients with progressive MS by evaluating subjects two years after treatment.
    [Neurology: Neuroimmunology & Neuroinflammation]

    Full Article

    Loss
    of FOXF1 Expression Promotes Human Lung-Resident Mesenchymal Stromal Cell Migration via ATX/LPA/LPA1 Signaling Axis

    Investigators demonstrated that Forkhead box F1 (FOXF1) expression acted as a restraint on the migratory function of lung-resident-MSCs via its role as a novel transcriptional repressor of autocrine motility-stimulating factor Autotaxin.
    [Scientific Reports]

    Full Article


    Latest updates and debates on mesenchymal stem cells.
    REVIEWS

    A Blueprint for Translational Regenerative Medicine

    The authors present a proposed blueprint for translational regenerative medicine. They offer principles to help guide the selection of cells and materials, present key in vivo imaging modalities, and argue that the host immune response should be considered throughout design and development.
    [Science Translational Medicine]

    Full Article

    INDUSTRY AND POLICY NEWS

    Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft Tissue

    Rafael Pharmaceuticals, Inc. announced it will initiate a Phase II clinical trial of CPI-613® in combination with hydroxychloroquine in patients with clear cell sarcoma of soft tissue. In partnership with Sara’s Cure and Sarcoma Alliance for Research through Collaboration (SARC), they will begin enrolling patients into the Simon two-stage design trial at sites across the US.
    [Rafael Pharmaceuticals, Inc. (GlobeNewswire, Inc.)]

    Press Release

    FEATURED EVENT

    International
    Conference on Stem Cell Differentiation and Epigenetic Regulation

    February 25 – February 26, 2021
    Virtual


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – MSC Therapeutics

    National University of Ireland Galway – Galway, Ireland

    Senior Research Technologist – Bone Marrow

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Fellow – Damaged Tissue Restoration

    University of Illinois at Chicago College of Medicine – Chicago, Illinois, United States

    Senior
    Scientist – Stem Cell Biology

    Ncardia – Share Gosselies, Belgium

    Research Professional – Life Sciences

    Stanford University – Stanford, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Mesenchymal Cell News
    Archives Contact Us
    Mesenchymal Cell News Twitter